These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8607405)

  • 1. Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node.
    Page RL; Wharton JM; Prystowsky EN
    Am J Cardiol; 1996 Feb; 77(4):260-5. PubMed ID: 8607405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
    Chiou CW; Chen SA; Kung MH; Chang MS; Prystowsky EN
    Circulation; 2003 May; 107(20):2583-8. PubMed ID: 12743004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous enhanced vagal tone on atrioventricular nodal and sinoatrial nodal function in humans.
    Page RL; Tang AS; Prystowsky EN
    Circ Res; 1991 Jun; 68(6):1614-20. PubMed ID: 2036714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective slow pathway ablation does not alter enhancement of vagal tone on sinus and atrioventricular nodal function.
    Olsovsky MR; Belz MK; Stambler BS; Gilligan DM; Wood MA; Ellenbogen KA
    Am J Cardiol; 1996 Dec; 78(11):1289-92. PubMed ID: 8960594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concealed conduction and dual pathway physiology of the atrioventricular node.
    Liu S; Olsson SB; Yang Y; Hertervig E; Kongstad O; Yuan S
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):144-9. PubMed ID: 15028041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased vagal cardiac nerve traffic prolongs ventricular refractoriness in patients undergoing electrophysiology testing.
    Ellenbogen KA; Smith ML; Eckberg DL
    Am J Cardiol; 1990 Jun; 65(20):1345-50. PubMed ID: 2343822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vagal modulation of the rate-dependent properties of the atrioventricular node.
    Nayebpour M; Talajic M; Villemaire C; Nattel S
    Circ Res; 1990 Nov; 67(5):1152-66. PubMed ID: 2171801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagally induced hyperpolarization in atrioventricular node.
    Mazgalev T; Dreifus LS; Michelson EL; Pelleg A
    Am J Physiol; 1986 Sep; 251(3 Pt 2):H631-43. PubMed ID: 3752273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of heart electrophysiological parameters after destruction of epicardial subplexuses that innervate sinoatrial node].
    Kulboka A; Veikutis V; Pauza DH; Lekas R
    Medicina (Kaunas); 2003; 39(6):589-95. PubMed ID: 12829884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of human atrioventricular nodal concealed conduction utilizing S1S2S3 stimulation.
    Wu D; Denes P; Dhingra RC; Wyndham CR; Rosen KM
    Circ Res; 1976 Nov; 39(5):659-65. PubMed ID: 184975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal tone augmentation to the atrioventricular node in humans: efficacy and safety of burst endocardial stimulation.
    Rossi P; Bianchi S; Monari G; Della Scala A; Porcelli D; Valsecchi S; Canonaco S; Kornet L; Azzolini P
    Heart Rhythm; 2010 May; 7(5):683-9. PubMed ID: 20206321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dobutamine and phenylephrine on atrioventricular conduction during combined use of halothane and thoracic epidural lidocaine.
    Nishikawa K; Yabe M; Mori T; Terai T; Yukioka H; Fujimori M
    Anesth Analg; 1996 Mar; 82(3):551-7. PubMed ID: 8623960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem on concealed atrioventricular nodal conduction in relation to ventricular response during atrial fibrillation in anesthetized dogs.
    Fujiki A; Mizumaki K; Tani M
    Am Heart J; 1993 May; 125(5 Pt 1):1284-9. PubMed ID: 8480579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phasic influences of vagal stimulation on atrioventricular conduction.
    Warner MR; Loeb JM
    Can J Physiol Pharmacol; 1988 Sep; 66(9):1198-205. PubMed ID: 3219664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventriculophasic modulation of atrioventricular nodal conduction in humans.
    Skanes AC; Tang AS
    Circulation; 1998 Jun; 97(22):2245-51. PubMed ID: 9631874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of postganglionic vagal stimulation on the organization of atrioventricular nodal conduction in isolated rabbit heart tissue.
    Mazgalev T; Dreifus LS; Michelson EL; Pelleg A
    Circulation; 1986 Oct; 74(4):869-80. PubMed ID: 3757195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of electrophysiological properties of neonatal canine heart by tonic parasympathetic stimulation.
    Pickoff AS; Stolfi A
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H38-44. PubMed ID: 2301613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation.
    van den Berg MP; Crijns HJ; Haaksma J; Brouwer J; Lie KI
    Clin Sci (Lond); 1994 May; 86(5):531-5. PubMed ID: 8033507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concealed conduction in nodal dual pathways: depressed conduction, prolonged refractoriness, or reset excitability cycle?
    Xu B; Billette J; Lavallée M
    Heart Rhythm; 2006 Feb; 3(2):212-21. PubMed ID: 16443539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.